Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Weight trajectories in virally suppressed people with HIV compared to matched people without HIV, and predictors of weight gain: a 3-year cohort study from the US TRIO Healthcare Network.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: September 02, 2026
Intraoperative Fungal and Acid-Fast Bacilli Culture Use in Orthopedic Surgery and the Cost to the Medical System: A Narrative Review.
Journal: Cureus
Published: February 03, 2026
Preexposure Prophylaxis Prescription Dispensation Status and HIV-1 Acquisition.
Journal: JAMA network open
Published: December 04, 2025
Treatment patterns, health care resource utilization, and costs of heavily treatment-experienced people with HIV in the United States.
Journal: Journal of managed care & specialty pharmacy
Published: November 26, 2025
Antiretroviral resistance in at least second-line HIV-1 treatment virologic failure with common InSTI-based regimens.
Journal: AIDS (London, England)
Published: September 05, 2025
Effectiveness of B/F/TAF in adults with HIV who are viremic with M184V/I.
Journal: AIDS research and therapy
Published: July 16, 2025
Health care provider- and patient-reported outcomes for bictegravir/emtricitabine/tenofovir alafenamide versus other antiretroviral regimens: an observational survey in the United States (July 2021-March 2022).
Journal: Current medical research and opinion
Published: June 17, 2025
Characterizing treatment interruptions in the OPERA cohort and virologic outcomes after resumption with bictegravir/emtricitabine/tenofovir alafenamide.
Journal: AIDS research and therapy
Published: April 30, 2025
Monitoring and risk of hepatitis B reactivation and hepatitis flare during tenofovir interruption among people with HIV and hepatitis B.
Journal: AIDS (London, England)
Published: April 15, 2025
Suppressed switch to Bictegravir/emtricitabine/tenofovir alafenamide compared with dolutegravir/lamivudine: Real-world evidence from the OPERA cohort.
Journal: HIV medicine
Published: March 18, 2025
Outcomes in people with HIV who resume or switch to bictegravir/emtricitabine/tenofovir alafenamide following a treatment interruption.
Journal: AIDS (London, England)
Published: December 17, 2024
Health care resource utilization and costs for treatment-experienced people with HIV switching or restarting antiretroviral regimens since 2018.
Journal: Journal of managed care & specialty pharmacy
Published: August 01, 2024
Last Updated: 09/26/2026